{
    "elements": [
        {
            "type": "image",
            "sequence_num": 1,
            "data": {
                "url": "12002 MRI Contrast Agent Administration 3.0.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 15,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Title:"
                    },
                    {
                        "text": "MRI CONTRAST AGENT ADMINISTRATION POLICY"
                    },
                    {
                        "text": "Document Reference/Register no:"
                    },
                    {
                        "text": "12002"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "3.0"
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP)"
                    },
                    {
                        "text": "Guideline"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "Referrers for MRI scans and all MRI staff"
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "th20 June 2019"
                    },
                    {
                        "text": "Review Date:"
                    },
                    {
                        "text": "th19 June 2022"
                    },
                    {
                        "text": "Developed in response to:"
                    },
                    {
                        "text": "The Royal College of Radiologists updated guidelines (Apr 2019) in response to the Medicines and Healthcare products Regulatory Agency (MHRA) drug safety updates (Feb 2018)"
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "9,11"
                    },
                    {
                        "text": "Issuing Division/Directorate:"
                    },
                    {
                        "text": "Therapies and Diagnostics"
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "Bridget McNulty, Advanced Practitioner MRI Radiographer; Barbara Chippendale, Clinical Specialist and Lead MRI Radiographer; Sharon Coyle Advanced Practitioner MRI Radiographer"
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box/es to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "MEHT \u25a1 BTUH \u25a1 SUH"
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "n/a"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "n/a"
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "Dr Pearl Wou MRI Lead/ Consultant Radiologist"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "16th May 2019"
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "DRAG Chairman's Action"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "20th June 2019"
                    },
                    {
                        "text": "Executive and Clinical Directors (Communication of minutes from Document Ratification Group"
                    },
                    {
                        "text": "Date: June 2019"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "Intranet & Website. Notified on Staff Focus"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "image",
            "sequence_num": 3,
            "data": {
                "url": "12002 MRI Contrast Agent Administration 3.0.002.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 7,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Consulted With:"
                    },
                    {
                        "text": "Post/ Approval Committee/ Group:"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Avril Waller"
                    },
                    {
                        "text": "MRI Advanced Practitioner Radiographer"
                    },
                    {
                        "text": "17th June 2019 18th June 2019"
                    },
                    {
                        "text": "Barbara Chippendale"
                    },
                    {
                        "text": "MRI Clinical Lead"
                    },
                    {
                        "text": "Bridget McNulty"
                    },
                    {
                        "text": "MRI Advanced Practitioner Radiographer"
                    },
                    {
                        "text": "Sharon Coyle"
                    },
                    {
                        "text": "MRI Advanced Practitioner Radiographer"
                    },
                    {
                        "text": "Dr N. Railton"
                    },
                    {
                        "text": "MEHT Consultant Radiologist and clinical director Radiology"
                    },
                    {
                        "text": "Alison Felton"
                    },
                    {
                        "text": "Head of Pharmacy"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 1,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "12044 MRI Operating Policy 08090 Patient Identification Policy 04071 Standard Infection Prevention 04072 Hand Hygiene 10004 Safe Handling & Disposal of Sharps 04088 Dispose of Waste Products 14019 PICC Mid Service Line Management 11011 Mental Capacity Act (2005) Policy 18024 Radiology generated blood request referrals made prior to imaging (to assess creatinine levels)"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 6,
            "data": {
                "num_rows": 12,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Review History:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/Reviewer:"
                    },
                    {
                        "text": "Summary of amendments/ Record documents superseded by:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Barbara Chippendale"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "February 2012"
                    },
                    {
                        "text": "2.0"
                    },
                    {
                        "text": "Barbara Chippendale"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "February 2016"
                    },
                    {
                        "text": "3.0"
                    },
                    {
                        "text": "Bridget McNulty & Sharon Coyle"
                    },
                    {
                        "text": "Full Review"
                    },
                    {
                        "text": "20th June 2019"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 7,
            "data": {
                "is_heading": 1,
                "text": "Index"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 8,
            "data": {
                "is_heading": 1,
                "text": "11: Communication and Implementation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 9,
            "data": {
                "is_heading": 1,
                "text": "12: References"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 10,
            "data": {
                "is_heading": 1,
                "text": "13: Glossary"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 11,
            "data": {
                "is_heading": 1,
                "text": "14: Appendix:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 12,
            "data": {
                "is_heading": 0,
                "text": "Appendix 1: Preliminary Impact Assessment"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 13,
            "data": {
                "is_heading": 0,
                "prefix": 1.1,
                "text": "To provide a written procedure for staff undertaking Gadolinium Based Contrast Agent (GBCA) IV Injections."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 14,
            "data": {
                "is_heading": 0,
                "prefix": 1.2,
                "text": "To provide a robust process for trust to administer MRI GBCAs appropriately following current guidelines from the Medicines and Healthcare Products Regulatory Agency (MHRA)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 15,
            "data": {
                "is_heading": 0,
                "prefix": 1.2,
                "text": "To allow safe administration of GBCAs."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 16,
            "data": {
                "is_heading": 0,
                "text": "1.2.1  Under instruction of the appropriate Patient Group Direction (PGD), to allow safe administration of GBCAs by radiographers."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 17,
            "data": {
                "is_heading": 0,
                "prefix": 1.3,
                "text": "It is known that GBCAs have the potential to cause Nephrogenic Systemic Fibrosis (NSF) which is a rare but potentially fatal condition. It has been found only in patients with severely impaired kidney function (see section 10.1)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 18,
            "data": {
                "is_heading": 0,
                "text": "1.3.1  Estimation of glomerular filtration rate (eGFR) can be used to assess a person's kidney function. It is necessary to obtain renal function blood tests prior to administering GBCAs to patients in MRI in the outlined qualifying category."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 19,
            "data": {
                "is_heading": 0,
                "prefix": 1.4,
                "text": "Recently, the general issue of gadolinium retention has come into the fore, spurring much on-going research. As a result, the marketing authorisations of some GBCAs have been withdrawn from use. The potential and theoretical risks of IV administration of GBCAs for MRI must be weighed against the potential benefits to the patient (see section 10.1)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 20,
            "data": {
                "is_heading": 0,
                "prefix": 2.1,
                "text": "To ensure a high-quality service is provided to the end service user."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 21,
            "data": {
                "is_heading": 0,
                "prefix": 2.2,
                "text": "To comply with current guidelines and evidence-based best practice."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 22,
            "data": {
                "is_heading": 0,
                "prefix": 2.3,
                "text": "To follow guidance for risk minimisation with use of GBCAs."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 23,
            "data": {
                "is_heading": 0,
                "prefix": 2.4,
                "text": "To allow safe administration of GBCAs and improve patient safety."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 24,
            "data": {
                "is_heading": 0,
                "prefix": 2.5,
                "text": "To prevent the risk of NSF in people with renal impairment who are to be administered GBCAs."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 25,
            "data": {
                "is_heading": 0,
                "prefix": 2.6,
                "text": "To allow GBCA enhanced scans to be performed as necessary and without delays, to assist patient management with valuable diagnostic information."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 26,
            "data": {
                "is_heading": 0,
                "text": "2.6.1  To ensure appropriate blood test results are available, at the referral vetting stage or when the patient arrives to their scan appointment."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 27,
            "data": {
                "is_heading": 1,
                "prefix": 2.7,
                "text": "To reduce the number of extravasations."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 28,
            "data": {
                "is_heading": 0,
                "prefix": 3.1,
                "text": "The target audience for this policy includes the radiographers and radiologists as justifiers of the examinations and administrators of IV contrast. This guidance should also be used by clinicians who refer patients for examinations involving IV contrast."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 29,
            "data": {
                "is_heading": 1,
                "prefix": 3.2,
                "text": "The referrer must provide sufficient clinical details in order to justify the MRI scan."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 30,
            "data": {
                "is_heading": 1,
                "prefix": 3.3,
                "text": "Contrast should only be administered when clinically indicated."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 31,
            "data": {
                "is_heading": 1,
                "prefix": 3.4,
                "text": "Caution is required with administration of GBCAs:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 32,
            "data": {
                "is_heading": 0,
                "text": "3.4.1 Patients with known hypersensitivities and history of allergies. When required, advice should always be taken from a Radiologist."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 33,
            "data": {
                "is_heading": 0,
                "text": "3.4.2 Pregnant patients: please refer to the MRI and pregnancy policy"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 34,
            "data": {
                "is_heading": 0,
                "text": "3.4.3 The referrer should highlight whether a patient has known poor renal function, or conditions to indicate renal impairment, or history of a previous contrast reaction, to support the decision making process."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 35,
            "data": {
                "is_heading": 0,
                "text": "3.4.4 Not all patients undergoing procedures involving IV GBCA administration require formal testing of their renal function prior to contrast media administration. The qualifying criteria determines eGFR requirement, as stipulated by the PGD for the relevant GBCA."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 36,
            "data": {
                "is_heading": 1,
                "text": "3.4.5 Qualifying criteria (any of the following):"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 37,
            "data": {
                "is_heading": 0,
                "text": "Patients over 65 years of age."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 38,
            "data": {
                "is_heading": 0,
                "text": "Any patient with known renal function impairment."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 39,
            "data": {
                "is_heading": 0,
                "text": "Patients in the peri-operative liver transplant period."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 40,
            "data": {
                "is_heading": 0,
                "text": "Chronic disease, e.g. Diabetes, which are associated with renal failure."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 41,
            "data": {
                "is_heading": 1,
                "text": "3.4.6 If patients have one or more of the qualifying criteria, then an eGFR value taken within the last 3 months is required; however, Patients presenting within the 3 month required timeframe, with a recorded renal function of   or  if they  are  acutely  unwell  (e.g.  Acute  Kidney Injury), must have an up to date eGFR value taken within 7 days of their scan (see PGDs for Primovist and Dotarem)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 42,
            "data": {
                "is_heading": 1,
                "text": "3.4.7 High volumes of GBCAs are nephrotoxic, and in the presence of renal impairment, there is potential for contrast-induced acute kidney injury (CI-AKI). Large volumes of GBCAs (>30mililitres [ml]) should not be used."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 43,
            "data": {
                "is_heading": 1,
                "prefix": 3.5,
                "text": "Pregnancy:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 44,
            "data": {
                "is_heading": 0,
                "text": "\u201cGBCAs should not be used during pregnancy unless the clinical condition of the patient makes their use absolutely necessary\u201d (as defined by the RCR Guidelines)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 45,
            "data": {
                "is_heading": 0,
                "text": "3.5.1  Breastfeeding:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 46,
            "data": {
                "is_heading": 0,
                "text": "The requirement for GBCA administration to a lactating mother is to be discussed with, and decided by the Radiologist. The continuation or cessation of breastfeeding for 24 hours should be at the discretion of the lactating mother, in consultation with the clinician (as Defined by the RCR Guidelines)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 47,
            "data": {
                "is_heading": 0,
                "prefix": 3.6,
                "text": "For children and neonates, it is advised that a Paediatric Radiologist should be consulted to discuss the requirement of GBCAs in MRI."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 48,
            "data": {
                "is_heading": 1,
                "text": "3.6.1  As per Departmental PGDs, Radiographers may only administer GBCAs to patients over 16 years. Only clinicians may inject children under 16 years of age."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 49,
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Roles and Responsibilities"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 50,
            "data": {
                "is_heading": 0,
                "prefix": 4.1,
                "text": "All healthcare and medical professionals have a responsibility to adhere to the principles described in this policy/ guideline."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 51,
            "data": {
                "is_heading": 0,
                "prefix": 4.2,
                "text": "The Radiologist is the advisory person for all queries."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 52,
            "data": {
                "is_heading": 0,
                "text": "4.2.1  The radiologist or clinician is to inject GBCAs to children under the age of 16 years, as per the departmental PGD."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 53,
            "data": {
                "is_heading": 0,
                "prefix": 4.3,
                "text": "Efficient practice may involve giving iodine-based and GBCAs for enhanced CT and MR on the same day:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 54,
            "data": {
                "is_heading": 0,
                "text": "For patients with normal to moderate renal function (GFR >30ml/min/1.73m2)- there should be 4 hours between these injections."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 55,
            "data": {
                "is_heading": 0,
                "text": "For patients with severely reduced renal function (GFR< 30ml/min/1.73m2 or on dialysis) - there should be 7 days between these injections."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 56,
            "data": {
                "is_heading": 0,
                "text": "(GBCAs attenuate X-rays well and may be misinterpreted on CT. For abdominal CT exams, CT contrast should be given before MRI contrast. For chest and brain examinations, either CT or MRI may be done first)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 57,
            "data": {
                "is_heading": 0,
                "prefix": 4.4,
                "text": "An individual or team trained in recognising and treating contrast reactions should be immediately available to the department where contrast is administered and must be contactable."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 58,
            "data": {
                "is_heading": 0,
                "prefix": 4.5,
                "text": "It is the referrer's responsibility to organise the blood test referral for their patient to ensure a current eGFR is available to assess at the referral vetting stage or prior to contrast administration. The patient qualifying criteria and blood test timing restrictions are outlined as per the above-mentioned PGDs."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 59,
            "data": {
                "is_heading": 0,
                "prefix": 4.6,
                "text": "In some extreme circumstances, where it is highlighted at the referral vetting stage that a patient requires a blood test for their MRI scan, the \u2018Radiology generated blood request referrals made prior to imaging (to assess creatinine levels)' Policy should be followed."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 60,
            "data": {
                "is_heading": 0,
                "prefix": 4.7,
                "text": "It is the radiographer's responsibility to review the blood test results. The administration of GBCA is then decided after consideration against the inclusion, exclusion and caution criteria set in the PGDs. Where necessary, advice should be sought from a radiologist."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 61,
            "data": {
                "is_heading": 0,
                "text": "4.7.1 The radiographer must ensure they have access to the Trusts electronic test results system (MEHT Review)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 62,
            "data": {
                "is_heading": 0,
                "text": "4.7.2 The radiographer must ensure accurate documentation of the blood test results on the Radiology Information System (RIS) and the MRI patient screening and exam paperwork, in line with the Trust's clinical record keeping standards."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 63,
            "data": {
                "is_heading": 0,
                "prefix": 4.8,
                "text": "Cannulation can sometimes be avoided if the patient presents with a trust"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 64,
            "data": {
                "is_heading": 0,
                "text": "recognised power injector safe, PICC Line. The radiographer is responsible for"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 65,
            "data": {
                "is_heading": 0,
                "text": "maintaining competency/training updates for this."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 66,
            "data": {
                "is_heading": 0,
                "prefix": 4.9,
                "text": "Power Injector Pump can be used as per MRI exam Protocol. This must be fully functional and in a serviceable condition. Power injectors are routinely serviced on a yearly basis."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 67,
            "data": {
                "is_heading": 0,
                "prefix": 4.1,
                "text": "Should there be any concerns about extravasation, follow the Extravasation Policy."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 68,
            "data": {
                "is_heading": 0,
                "prefix": 5.1,
                "text": "All staff must follow Trust guidelines on infection control by  ensuring that they effectively  decontaminate  their  hands  before  and  after  undertaking  any  patient contact, clean the patient's skin correctly and follow safe disposal of sharps protocol as per the Trust guidelines."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 69,
            "data": {
                "is_heading": 0,
                "prefix": 6.1,
                "text": "Mid Essex Hospital Services NHS Trust is committed to the provision of a service that is fair accessible and meets the needs of all individuals (http://meht- intranet/hr/equality-and-diversity/ intranet link). (Refer to Appendix 1)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 70,
            "data": {
                "is_heading": 0,
                "prefix": 7.1,
                "text": "All Radiographers who perform IV cannulation must have completed a \"Certificate of Competence in Administering Intravenous Injections\". This form of university based qualification must be awarded by an institution that has been accredited by the College of Radiographers (CoR)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 71,
            "data": {
                "is_heading": 0,
                "prefix": 7.2,
                "text": "Radiographers must be familiar with all details of the department's Patient Group Directions (PGDs), to adhere to these instructions, to allow safe administration of GBCAs."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 72,
            "data": {
                "is_heading": 0,
                "prefix": 7.3,
                "text": "Radiographers are responsible for maintaining their own continued professional development and maintaining their professional standards, through practice, reflection and self-audit."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 73,
            "data": {
                "is_heading": 0,
                "prefix": 7.4,
                "text": "The Radiographer must have attended Basic Life Support (BLS) training. This local, mandatory training course also requires attending a refresher programme every two years as per trust policy(http://meht-intranet/clinical-pages/resuscitation- department-and-tart/ intranet link)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 74,
            "data": {
                "is_heading": 0,
                "prefix": 7.5,
                "text": "All referrers must be aware of the requirement of a current eGFR and to organise the blood test referral, to those patients in the qualifying category, prior to contrast administration."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 75,
            "data": {
                "is_heading": 0,
                "prefix": 7.6,
                "text": "All radiologists and suitable clinicians must be aware of criteria under which they may be required to administer GBCAs, while remaining in adherence to this policy."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 76,
            "data": {
                "is_heading": 0,
                "prefix": 7.7,
                "text": "As an integral part of the knowledge skills framework (KSF), staffs are appraised annually to ensure competency in the core dimensions for their professional post and continued development."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 77,
            "data": {
                "is_heading": 0,
                "prefix": 8.1,
                "text": "In the event of a breach of policy, a Datix will be completed as per Trust policy (http://datixlive/datix/live/index.php intranet link), alongside departmental escalation procedure."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 78,
            "data": {
                "is_heading": 0,
                "prefix": 9.1,
                "text": "The risk management lead will review all datixes. Any immediate training or educational issues relating to lack of compliance with this guideline will be addressed on a one to one basis."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 79,
            "data": {
                "is_heading": 0,
                "prefix": 9.2,
                "text": "A quarterly audit of compliance will be undertaken by reviewing all risk events related to the operation of this clinical guideline."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 80,
            "data": {
                "is_heading": 0,
                "prefix": 9.3,
                "text": "All incidents and any trend analysis will be reviewed at the radiology audit meeting."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 81,
            "data": {
                "is_heading": 0,
                "prefix": 9.4,
                "text": "All incidents reported on the electronic incident reporting system will be reviewed daily and investigated. Yearly analysis will be carried out to highlight any problem areas. These areas will then be assessed and appropriate adaptations made to prevent further breaches of policy."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 82,
            "data": {
                "is_heading": 0,
                "prefix": 9.5,
                "text": "If further medical research produces changes to the national guidelines this policy will be updated to comply with the findings/recommendations."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 83,
            "data": {
                "is_heading": 0,
                "prefix": 9.6,
                "text": "Contrast reactions will be recorded using the MHRA's yellow card system and on the incident reporting electronic Datix system."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 84,
            "data": {
                "is_heading": 0,
                "prefix": 10.1,
                "text": "Further reading:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 85,
            "data": {
                "is_heading": 0,
                "text": "Gadolinium deposition and the potential for toxicological sequelae - A literature review of issues surrounding gadolinium-based contrast agents."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 86,
            "data": {
                "is_heading": 0,
                "text": "Layne, Kerry A; Dargan, Paul I; Archer, John R H; Wood, David M"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 87,
            "data": {
                "is_heading": 0,
                "text": "British journal of clinical pharmacology; Nov 2018; vol.84 (no. 11); p.2522-2534. https://doi.org/10.1111/bcp.13718 [accessed 23/05/19]"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 88,
            "data": {
                "is_heading": 0,
                "text": "Gadolinium-based contrast agents: A comprehensive risk assessment. Fraum, Tyler J; Ludwig, Daniel R; Bashir, Mustafa R; Fowler, Kathryn J"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 89,
            "data": {
                "is_heading": 0,
                "prefix": 46.0,
                "text": "Journal of magnetic resonance imaging : JMRI; Aug 2017; vol.  (no. 2); p. 338- 353 https://doi.org/10.1002/jmri.25625 [accessed 23/05/19]"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 90,
            "data": {
                "is_heading": 0,
                "text": "Nephrogenic Systemic Fibrosis: A review if history, pathophysiology and current guidelines.Hazelton, Julian M; Chiu, Michael K; Abujudeh, Hani H."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 91,
            "data": {
                "is_heading": 0,
                "text": "Current Radiology Reports: Fab 2019; 7:5 [accessed 24/05/19]"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 92,
            "data": {
                "is_heading": 0,
                "text": "Patient Group Directions (PGDs) for administration of contrast media in radiology services and exemplar PGD templates- 02/04/2019 https://www.sps.nhs.uk/articles/patient-group-directions-pgds-for-administration-of- contrast-media-in-radiology-services/ [accessed 12/06/2019]"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 93,
            "data": {
                "is_heading": 0,
                "text": "ESUR Guidelines on Contrast Agents v10.0 (March 2018) http://www.esur-cm.org/ [accessed 12/06/2019]"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 94,
            "data": {
                "is_heading": 0,
                "prefix": 11.1,
                "text": "Corporate services will ensure the policy is uploaded to the intranet and website and notified on Communications posts."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 95,
            "data": {
                "is_heading": 0,
                "prefix": 11.2,
                "text": "It is the responsibility of the author to ensure that all MRI staff are provided with an electronic copy of the document, this document is saved to the radiology shared drive."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 96,
            "data": {
                "is_heading": 0,
                "text": "Medicines and Healthcare Products Regulatory Agency (2015) Safety guidelines for Magnetic resonance imaging equipment in clinical use. London: Medicines and Healthcare Products Regulatory Agency. Available at:https://www.gov.uk/government/publications/safety-guidelines-for-magnetic- resonance-imaging-equipment-in-clinical-use [accessed 22/05/19]"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 97,
            "data": {
                "is_heading": 0,
                "text": "RCR Guidance on gadolinium-based contrast agent administration to adult patients (Apr  2019) https://www.rcr.ac.uk/system/files/publication/field_publication_files/bfcr193- gadolinium-based-contrast-agent-adult-patients.pdf [accessed 22/05/19]"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 98,
            "data": {
                "is_heading": 0,
                "text": "RCR Standards for intravascular contrast administration to adult patients (Feb 2015) https://www.rcr.ac.uk/sites/default/files/Intravasc_contrast_web.pdf [accessed 21/05/19]"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 99,
            "data": {
                "is_heading": 0,
                "text": "MHRA/ GOV.UK Drug safety update-\u2018Gadolinium-containing contrast agents: removal of Omniscan and iv Magnevist, restrictions to the use of other linear agents (Feb 2018)  https://www.gov.uk/drug-safety-update/gadolinium-containing-contrast- agents-removal-of-omniscan-and-iv-magnevist-restrictions-to-the-use-of-other- linear-agents [accessed 22/05/19]"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 100,
            "data": {
                "is_heading": 0,
                "text": "MHRA/ GOV.UK Drug safety unpdate- \u2018Gadolinium-containing contrast agents:Omniscan and iv Magnevist no longer authoried, MultiHance and Primovist for use only in liver imaging (Feb2018)  https://www.gov.uk/drug-safety- update/gadolinium-containing-contrast-agents-omniscan-and-iv-magnevist-no- longer-authorised-multihance-and-primovist-for-use-only-in-liver-imaging  [accessed 22/05/19"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 101,
            "data": {
                "is_heading": 0,
                "text": "MHRA/ GOV.UK Drug safety update- \u2018Gadolinium-containing contrast agents:Omniscan and iv Magnevist no longer authorised, MultiHance and Primovist for use only in liver imaging (Feb 2018)  https://www.gov.uk/drug-safety- update/gadolinium-containing-contrast-agents-omniscan-and-iv-magnevist-no- longer-authorised-multihance-and-primovist-for-use-only-in-liver-imaging  [accessed 22/05/2019]"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 102,
            "data": {
                "is_heading": 0,
                "text": "Hand Hygiene Training  http://meht-intranet/hr/learning-and-development/training- films/hand-hygiene-training-both-clinical-non-clinical/ [accessed 21/05/19]"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 103,
            "data": {
                "is_heading": 0,
                "text": "ANTT cannulation  http://meht-intranet/hr/learning-and-development/training- films/antt-approach-cannulation/  [accessed 21/05/19]"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 104,
            "data": {
                "is_heading": 0,
                "text": "Safe Handling and Disposal of Sharps Policy  http://meht- intranet/EasysiteWeb/getresource.axd?AssetID=111183&type=full&servicetype=Att achment [accessed 21/05/19]"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 105,
            "data": {
                "is_heading": 0,
                "text": "Extravasation guidelines  http://meht- intranet/EasysiteWeb/getresource.axd?AssetID=21846&type=full&servicetype=Atta chment accessed [21/05/19]"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 106,
            "data": {
                "is_heading": 0,
                "text": "Equality and Diversity Policy  http://meht- intranet/EasysiteWeb/getresource.axd?AssetID=5471&type=full&servicetype=Attac hment accessed [21/05/19]"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 107,
            "data": {
                "is_heading": 0,
                "text": "The Royal Australian and New Zealand College of radiologists. Iodinated contrast media guideline (2018) .https://www.google.co.uk/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=2ah UKEwikvpa- p6_iAhU0SxUIHdWbBocQFjAAegQIBRAC&url=https%3A%2F%2Fwww.ranzcr.com %2Fdocuments%2F573-iodinated-contrast-guidelines- 2016%2Ffile&usg=AOvVaw079hLpfatIYAydeCp0bSce"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 108,
            "data": {
                "is_heading": 0,
                "text": "Gadolinium deposition and the potential for toxicological sequelae - A literature review of issues surrounding gadolinium-based contrast agents."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 109,
            "data": {
                "is_heading": 0,
                "text": "Layne, Kerry A; Dargan, Paul I; Archer, John R H; Wood, David M"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 110,
            "data": {
                "is_heading": 0,
                "text": "British journal of clinical pharmacology; Nov 2018; vol.84 (no. 11); p.2522-2534. https://doi.org/10.1111/bcp.13718 [accessed 23/05/19]"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 111,
            "data": {
                "is_heading": 0,
                "prefix": 2018.0,
                "text": "ESUR  guidelines  on  Contrast  Media   Can  Iodine-  and  Gadolinium-based contrast agents safely be given on the same day for routine examinations? (B.6.). http://www.esur-cm.org/index.php/b-renal-adverse-reactions-2 [accessed 12/06/19]"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 112,
            "data": {
                "is_heading": 1,
                "text": "eGFR   Estimated Glomerular Filtration Rate NSF  Nephrogenic Systemic Fibrosis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 113,
            "data": {
                "is_heading": 1,
                "text": "IV Intravenous"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 114,
            "data": {
                "is_heading": 1,
                "text": "GBCA Gadolinium-based Contrast Agent PGD Patient Group Direction"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 115,
            "data": {
                "is_heading": 1,
                "text": "MRI Magnetic Resonance Imaging CI-AKI  Contrast-induced acute kidney injury"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 116,
            "data": {
                "is_heading": 0,
                "text": "12002 MRI Contrast Agent Administration 3.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 117,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": ""
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 118,
            "data": {
                "is_heading": 0,
                "text": "12002 MRI Contrast Agent Administration 3.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 119,
            "data": {
                "is_heading": 1,
                "text": "Appendix 1: Preliminary Equality Analysis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 120,
            "data": {
                "is_heading": 1,
                "text": "This assessment relates to: 12002 MRI Contrast Agent Administration"
            }
        },
        {
            "type": "table",
            "sequence_num": 121,
            "data": {
                "num_rows": 9,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "A change in a service to patients"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "A change to an existing policy"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "A change to the way staff work"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "A new policy"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Something else (please give details)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Questions"
                    },
                    {
                        "text": "Answers"
                    },
                    {
                        "text": "What are you proposing to change?"
                    },
                    {
                        "text": "Full Review"
                    },
                    {
                        "text": "Why are you making this change? (What will the change achieve?)"
                    },
                    {
                        "text": "3 year review"
                    },
                    {
                        "text": "Who benefits from this change and how?"
                    },
                    {
                        "text": "Patients and clinicians"
                    },
                    {
                        "text": "Is anyone likely to suffer any negative impact as a result of this change? If no, please record reasons here and sign and date this assessment. If yes, please complete a full EIA."
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": "a) Will you be undertaking any consultation as part of this change? b) If so, with whom?"
                    },
                    {
                        "text": "Refer to pages 1 and 2"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 122,
            "data": {
                "is_heading": 1,
                "text": "Preliminary analysis completed by:"
            }
        },
        {
            "type": "table",
            "sequence_num": 123,
            "data": {
                "num_rows": 1,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": "Name"
                    },
                    {
                        "text": "Barbara Chippendale"
                    },
                    {
                        "text": "Job Title"
                    },
                    {
                        "text": "MRI Clinical Specialist"
                    },
                    {
                        "text": "Date"
                    },
                    {
                        "text": "May 2019"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 124,
            "data": {
                "is_heading": 0,
                "prefix": 12.0,
                "text": ""
            }
        }
    ]
}